Ir al contenido principal

mevalonate kinase

El MVK gene provides instructions for making the mevalonate kinase enzyme. This enzyme converts a substance called mevalonic acid into mevalonate-5-phosphate. This conversion is the second step in a pathway that produces cholesterol. The cholesterol is later converted into steroid hormones and bile acids. Steroid hormones are needed for normal development and reproduction, and bile acids are used to digest fats. Mevalonate kinase also helps to produce other substances that are necessary for certain cellular functions, such as cell growth, cell maturation (differentiation), formation of the cell's structural framework (the cytoskeleton), gene activity (expression), and protein production and modification.

Selecciones de videos para Genes
Biblioteca de videos

Normal function

El MVK gene provides instructions for making the mevalonate kinase enzyme. This enzyme converts a substance called mevalonic acid into mevalonate-5-phosphate. This conversion is the second step in a pathway that produces cholesterol. The cholesterol is later converted into steroid hormones and bile acids. Steroid hormones are needed for normal development and reproduction, and bile acids are used to digest fats. Mevalonate kinase also helps to produce other substances that are necessary for certain cellular functions, such as cell growth, cell maturation (differentiation), formation of the cell's structural framework (the cytoskeleton), gene activity (expression), and protein production and modification.

Conditions referring to this gene or chromosome

Otros nombres

KIME_HUMAN

LH receptor mRNA-binding protein

LRBP

mevalonate kinase 1

MK

MVLK

Related patient information and medicines

Distrofia muscular

Patient information leaflet

Distrofia muscular

Also, if a child has delayed motor milestones (as mentioned above), a doctor may advise testing for MD, even though the problem could be due to another cause. MD may be diagnosed using one or more of the following tests: A blood test Blood tests for creatine kinase (CK) - in many types of MD, the blood level of CK is very high. A muscle biopsy.

Trastornos del almacenamiento de glucógeno

Patient information leaflet

Trastornos del almacenamiento de glucógeno

Trastornos del almacenamiento de glucógeno are a group of inherited diseases. They result from a problem with one of the proteins (known as enzymes) involved in the conversion of glucose to glycogen, or the breakdown of glycogen back into glucose. They mostly tend to affect your liver and muscles. Most are diagnosed in childhood. Symptoms include weakness,.

Cáncer de boca

Patient information leaflet

Cáncer de boca

Cáncer de boca is also sometimes called oral cancer. Diagnosing mouth cancer Your healthcare professional may suspect mouth cancer if y... Dr Krishna Vakharia , 16th October 2023 The National Institute for Health and Care Excellence (NICE) has recommended that a person should receive a diagnosis or ruling out of cancer within 28 days of being.

Distrofia muscular de Duchenne

Patient information leaflet

Distrofia muscular de Duchenne

What causes Duchenne muscular dystrophy. Distrofia muscular de Duchenne is caused by a genetic change which affects the muscles. Muscles contain a protein called dystrophin, which is necess... This tests for creatine kinase. Children with DMD always have a very high level of creatine kinase (about 10-100 times normal). Therefore, if a child's.

Pompholyx

Patient information leaflet

Pompholyx

Its effectiveness for pompholyx is still being studied, so it is not recommended yet. Dapilumab : this medication is used for a type of eczema called atopic dermatitis. In some cases it has been shown to be helpful for the treatment of pompholyx. Janus Kinase (JAK) inhibitors : these medications, available as creams or pills, target specific.

Myelofibrosis

Patient information leaflet

Myelofibrosis

Myelofibrosis is a serious bone marrow disorder that disrupts your body's normal production of blood cells. ...ed by myelofibrosis is a mutation in Janus Kinase 2 (JAK2)Dr Sarah Jarvis, December 2021 NICE guidance on drug treatments for myelofibrosis Fedratinib for treating disease-related splenomegaly or symptoms in myelofibrosis The National.

Historial del artículo

La información en esta página está escrita y revisada por pares por clínicos calificados.
  • 18 Aug 2020 | Última versión
  • 1 Apr 2011 | Publicado originalmente

Únete a la conversación

Comparte tus pensamientos o experiencias con otros en nuestro comunidades de pacientes.

Aviso legal: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Farmacia en línea, tratamientos y servicios de salud

Acceso sencillo a tratamientos y servicios de salud confiables en línea.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Suscríbete al boletín de Patient

Tu dosis semanal de consejos de salud claros y confiables, escritos para ayudarte a sentirte informado, seguro y en control.

Por favor, introduce una dirección de correo electrónico válida

Al suscribirte aceptas nuestros Política de Privacidad. Puedes darte de baja en cualquier momento. Nunca vendemos tus datos.